DCLK1 and cancer: After implementing a series of subgroup analysis, we noticed that high expression of DCLK1 was significantly correlated with poorly differentiated cancers, positive lymph node metastasis and advanced clinical stage, suggesting that overexpression of DCLK1 markedly accelerated the pathogenesis and development of cancer.